Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.
about
Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cellsPregnancy-specific glycoprotein 1 induces endothelial tubulogenesis through interaction with cell surface proteoglycansCombined strong anion-exchange HPLC and PAGE approach for the purification of heparan sulphate oligosaccharidesTransmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to HeparinComplement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeHeparan sulfate 3-O-sulfation: a rare modification in search of a function.Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence.Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.Differential regulation of endothelial cell activation by complement and interleukin 1alphaNormal levels of anticoagulant heparan sulfate are not essential for normal hemostasisHeparan sulfate: antithrombotic or not?Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging StudySuppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.Cardiovascular gene delivery: The good road is awaitingInteractions between coagulation and complement--their role in inflammationEndothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejectionComplement-mediated regulation of tissue factor activity in endothelium.Expression of a Xenopus counterpart of mammalian syndecan 2 during embryogenesisTumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cellsHuman follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity.Which anti-platelet therapies might be beneficial in xenotransplantation?The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells.The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.Glycosaminoglycans and the regulation of blood coagulation.Ecto-phosphorylation on aortic endothelial cells. Exquisite sensitivity to staurosporine.Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta.Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.Identification of the core proteins in proteoglycans synthesized by vascular endothelial cellsHeterogeneity of rat skin heparin chains with high affinity for antithrombin.Heterogeneous distribution of antithrombin-binding sites in rat brain heparan sulphate proteoglycans.Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
P2860
Q24314822-F985A8A3-4B35-4DAC-AA62-94F31E3C042AQ24614349-B5E52802-DC2E-4794-AAF4-7C922F0549B0Q28348093-D9914D9D-10AB-4B98-A41A-CE8EE00002F7Q28567433-BADA9744-0CDC-477F-BE10-5A061E930A8AQ33396792-F2832D87-DC5D-4070-B4A7-C1EE89BB6BB3Q33690545-B9EFFC82-2550-4FCB-A469-051373F572F7Q33926104-E9562B38-EF0A-4B45-93FD-D1B65847C9BEQ34634205-7B8B51E2-77FA-46FE-89B6-030A489CF35FQ34684891-2362CC83-B83F-4EFE-AC0A-2A430E2F4ABBQ34803633-147F99C7-2CB1-4606-8C05-3EEBDE41149BQ34889931-E51CA98B-4DAC-43BC-84BD-F87A4D58C8A0Q35096964-F64074AE-705B-4CE1-B552-094F64608763Q35582687-C8C8CA94-53B0-4D3A-B787-6E6CEF59B555Q35582723-6777D585-D283-4822-9AED-378E36BDA7F3Q35812051-A4740A66-16B5-475C-8DF7-CD5DC79C54BFQ35915765-826D489D-D205-4EBF-9A74-A421B63E2FD3Q36022738-794C6423-3DFB-4655-ABCD-5585E3BF2A27Q36219245-046025F6-7D57-452C-A126-6D5EDFD2A714Q36350925-1E350161-0A68-4C04-8D09-4D61F9B75C25Q36365648-98C322BD-57A6-467F-BD27-D5A92C723CCFQ36688083-B2A5CC20-B70C-455A-BA3E-1E02B680A323Q36851476-526CAA5A-0927-44B6-AD60-3C6077E77C89Q36940425-35BB3F64-FCA0-4B3F-9750-9E39500E6977Q37069089-C7E36199-7DBE-48BC-A6DC-07CA1B95A07DQ37447881-B44196EA-A46F-41AB-9BA6-A9EFB1D4A6FCQ37777806-C2CC713F-E9BA-4EC5-BA59-6B5630CC291AQ38341157-2D22868A-2BA8-4484-9383-C4F5700BE69EQ38348387-9937BDD4-5E2A-4AE4-95FB-F844EBFDDF49Q39368580-40E7350D-4840-459B-8FE0-065FE0945152Q39580237-2898E68F-C46B-4609-9048-ADCFBA0A10D6Q40304955-5BB7E09B-3DAF-4D42-9BD3-FA55DB0C0CD6Q40336362-040A6661-D88F-4AA9-A84D-3DA779BA1374Q40851193-95360912-3E79-4734-A34E-C3078F70694BQ41128294-2C466F20-8152-4EB3-922A-B7844BBB794BQ41197917-E76DA765-51C9-4B76-BC9E-E50A3C729A76Q41525659-85F95EC5-6F77-4F35-84BE-71BA96061ABCQ41782674-437E975C-B374-4B36-BA69-63C29E13A75FQ41820574-B075EEA5-5B3A-42F6-AAF8-6917CC067FE7Q41838341-A13F8FC0-E1AB-415B-ADEE-506AE3D83E59Q41839110-AFE53961-45A8-48E4-BEAD-F16142401CD1
P2860
Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Cloned bovine aortic endotheli ...... heparan sulfate proteoglycan.
@en
type
label
Cloned bovine aortic endotheli ...... heparan sulfate proteoglycan.
@en
prefLabel
Cloned bovine aortic endotheli ...... heparan sulfate proteoglycan.
@en
P2093
P921
P1476
Cloned bovine aortic endotheli ...... heparan sulfate proteoglycan.
@en
P2093
P304
P407
P577
1986-06-01T00:00:00Z